129 related articles for article (PubMed ID: 32468012)
1. A novel highly frequent single‑nucleotide polymorphism site of cadherin 23 in clear cell renal cell carcinoma with sarcomatoid differentiation based on whole exome sequencing.
Yu W; Wang X; Wang Y; Jiang Y; Zhang W; Shi H; Li Y
Oncol Rep; 2020 Aug; 44(2):735-746. PubMed ID: 32468012
[TBL] [Abstract][Full Text] [Related]
2. [Whole exome sequencing reveals molecular mechanisms of clear cell renal cell carcinoma with sarcomatoid differentiation].
Yu WJ; Jiang YX; Zhang W; Li GQ; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):756-761. PubMed ID: 34405610
[No Abstract] [Full Text] [Related]
3. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.
Bi M; Zhao S; Said JW; Merino MJ; Adeniran AJ; Xie Z; Nawaf CB; Choi J; Belldegrun AS; Pantuck AJ; Kluger HM; Bilgüvar K; Lifton RP; Shuch B
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2170-5. PubMed ID: 26864202
[TBL] [Abstract][Full Text] [Related]
4. Identification of Novel
Ramzan K; Al-Numair NS; Al-Ageel S; Elbaik L; Sakati N; Al-Hazzaa SAF; Al-Owain M; Imtiaz F
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33316915
[TBL] [Abstract][Full Text] [Related]
5. Low-grade spindle cell proliferation in clear cell renal cell carcinoma is unlikely to be an initial step in sarcomatoid differentiation.
Tanas Isikci O; He H; Grossmann P; Alaghehbandan R; Ulamec M; Michalova K; Pivovarcikova K; Montiel DP; Ondic O; Daum O; Prochazkova K; Hora M; Michal M; Hes O
Histopathology; 2018 Apr; 72(5):804-813. PubMed ID: 29194709
[TBL] [Abstract][Full Text] [Related]
6. Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.
Mikami S; Mizuno R; Kosaka T; Saya H; Oya M; Okada Y
Int J Cancer; 2015 Apr; 136(7):1504-14. PubMed ID: 25123505
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas.
Lee YM; Kim JM; Lee HJ; Seong IO; Kim KH
Urol Oncol; 2019 Oct; 37(10):742-748. PubMed ID: 31053527
[TBL] [Abstract][Full Text] [Related]
9. Epithelial to Mesenchymal Transition in Clear Cell Renal Cell Carcinoma with Rhabdoid Features.
Sugimoto M; Kohashi K; Itsumi M; Shiota M; Abe T; Yamada Y; Kuroiwa K; Naito S; Oda Y
Pathobiology; 2016; 83(6):277-86. PubMed ID: 27225469
[TBL] [Abstract][Full Text] [Related]
10. FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ≤7-cm clear cell renal cell carcinomas.
Ahn J; Han KS; Heo JH; Bang D; Kang YH; Jin HA; Hong SJ; Lee JH; Ham WS
Oncotarget; 2016 Aug; 7(32):51423-51434. PubMed ID: 27283491
[TBL] [Abstract][Full Text] [Related]
11. Identification of CDH23 mutations in Korean families with hearing loss by whole-exome sequencing.
Woo HM; Park HJ; Park MH; Kim BY; Shin JW; Yoo WG; Koo SK
BMC Med Genet; 2014 Apr; 15():46. PubMed ID: 24767429
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma.
Wu S; Wang Y; Sun L; Zhang Z; Jiang Z; Qin Z; Han H; Liu Z; Li X; Tang A; Gui Y; Cai Z; Zhou F
BMC Cancer; 2011 Sep; 11():413. PubMed ID: 21943117
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Expression of E-cadherin, N-cadherin, and P-cadherin in Clear Cell Renal Cell Carcinoma: Association With Adverse Clinicopathologic Factors and Poor Prognosis.
Jang NR; Choi JH; Gu MJ
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):223-230. PubMed ID: 32341236
[TBL] [Abstract][Full Text] [Related]
14. Inverse correlation of miR-27a-3p and CDH5 expression serves as a diagnostic biomarker of proliferation and metastasis of clear cell renal carcinoma.
Wang Y; Zhou X; Han P; Lu Y; Zhong X; Yang Y; Li D; Liu D; Li Q; Pan N; Mo Y; Luo W; Li P; Zhou X; Liudmila M
Pathol Res Pract; 2021 Apr; 220():153393. PubMed ID: 33740544
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of pregnancy up-regulated non-ubiquitous calmodulin kinase is associated with poor prognosis in clear cell renal cell carcinoma.
Wu S; Lv Z; Wang Y; Sun L; Jiang Z; Xu C; Zhao J; Sun X; Li X; Hu L; Tang A; Gui Y; Zhou F; Cai Z; Wang R
PLoS One; 2013; 8(4):e59936. PubMed ID: 23634203
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
[TBL] [Abstract][Full Text] [Related]
17. [Relationship research among CDH23 gene and the risk of noise-induced hearing loss].
Jiao J; Gu GZ; Chen GS; Zhang HL; Wu H; Li YH; Zhou WH; Yu SF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Feb; 38(2):84-90. PubMed ID: 32306668
[No Abstract] [Full Text] [Related]
18. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma.
Campos C; Fragoso S; Luís R; Pinto F; Brito C; Esteves S; Pataco M; Santos S; Machado P; Vicente JB; Rosa JC; Cavaco BM; Moura C; Pojo M
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32276436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
